Researchers discover camelid-derived two nanobodies that target SARS-CoV-2
| Date | 23rd, Jul 2021 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
A new study has been published on the bioRxiv* preprint server, which has identified and characterized two RBD-targeting neutralizing nanobodies, namely, DL4 and DL28.